Sort   by:  
 Page size 
UnknownBest therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis.
Not available
S-EPMC12832964 | biostudies-literature
UnknownNon-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE study.
Not available
S-EPMC10725369 | biostudies-literature
UnknownA pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients.
Not available
S-EPMC8938486 | biostudies-literature
UnknownThe Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study.
Not available
S-EPMC9056437 | biostudies-literature
UnknownUsing peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis.
Not available
S-EPMC10583024 | biostudies-literature
UnknownSymptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.
Not available
S-EPMC7649863 | biostudies-literature
UnknownAssociation of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors.
Not available
S-EPMC8874344 | biostudies-literature
UnknownClinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET).
Not available
S-EPMC12657748 | biostudies-literature
UnknownA prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
Not available
S-EPMC12056793 | biostudies-literature
Sort   by:  
 Page size